Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Unspecified Adult Solid Tumor, Protocol Specific 5 Melanoma 4 Prostatic Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lung Neoplasms 2 Hepatitis C 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Rhabdomyosarcoma 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neurofibrosarcoma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Malignant mesenchymal tumor 1 Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 101 Etoposide 60 Carboplatin 55 Vincristine 51 Filgrastim 49 Topotecan 44 Temozolomide 44 Melphalan 44 Isotretinoin 44 Doxorubicin 44 Irinotecan 42 Cisplatin 35 3-Iodobenzylguanidine 34 Peripheral Blood Stem Cell Transplantation 31 dinutuximab 30 Granulocyte Colony-Stimulating Factor 30 Radiotherapy 29 sargramostim 28 Granulocyte-Macrophage Colony-Stimulating Factor 25 Busulfan 22 Magnetic Resonance Spectroscopy 19 aldesleukin 18 Thiotepa 18 fludarabine 17 Interleukin-2 17 humanized 3F8 anti-GD2 monoclonal antibody 16 etoposide phosphate 16 naxitamab 15 Ifosfamide 15 Biopsy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Chromatography, High Pressure Liquid × Clear all

NCT00646230 2026-04-14

IV Fenretinide

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡